readthroughSign in
CompanySCTXNasdaqAlameda, CA

Scribe Therapeutics, Inc.

Scribe Therapeutics is a clinical-stage biotechnology company developing in vivo CRISPR-based genetic medicines for cardiometabolic diseases.

SCHEDULE 13GNov 16Latest SEC filing
Nov 12Latest story